Defending the mucosa: adjuvant and carrier formulations for mucosal immunity.


A majority of infectious microorganisms either colonize or cross mucosal surfaces to enter the host. A major goal in vaccine design is to induce a protective, lasting immune response against potential pathogens at mucosal surfaces. In addition, mucosal vaccines can offer needle-free delivery, thereby improving accessibility, safety, and cost-effectiveness… (More)
DOI: 10.1016/j.coi.2011.03.009